🔴 ProMIS Neurosciences is trading 5.77% down amid broader market weakness

ProMIS Neurosciences is trading at $8.16, with a -5.77% change amid broader market weakness.

• No company-specific announcement explaining the October 14 decline was identified; the latest listed company release is dated October 6.
• The biotech XBI sector is down 2.01%, and major U.S. indexes are also lower.
• Hotter-than-expected September CPI renewed rate concerns and pressured growth-sensitive stocks; this backdrop may be contributing but does not establish a company-specific catalyst.